50 /100
MEDIUM RISK
Score updated May 30, 2026

GNLN — Greenlane Holdings, Inc. Dilution Risk Tracker

Track GNLN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GNLN — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
30
⚠️ Warrant Exposure
90
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
42%
📜 Warrant Exercise 60%
• Massive warrant overhang: 256% of shares outstanding
• Warrant risk score very high (90/100)
📉 Score Deterioration 40%
• Score rose 30 points recently (worsening)
🔔 Track GNLN — Get forecast alerts →

💹 Market Data

Market Cap$2.19M
Shares Outstanding631.5K
Float627.1K
Cash$13.32M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 223.7% shares (2025Q4 vs prior)
11 institutional holders · 219.0K shares
#1 CoinFund Management LLC 169.7K shares
#2 VANGUARD GROUP INC 35.3K shares
#3 Virtu Financial LLC 10.2K shares
+ 8 more holders Sign up free to view →

📉 Short Interest

Short Interest14.9K
Days to Cover1.0
% of Float2.4%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jun 30, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2022
8-K 8K EVENT Apr 27, 2026
4 INSIDER TRANSACTION Apr 02, 2026
3 FORM3 Mar 17, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track GNLN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GNLN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for GNLN
📊 GNLN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 GNLN Signal Convergence & Dark Pool Activity — StonkWhisper 📄 GNLN Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.